HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

TDOC

Teladoc Health, Inc. (NYSE)

Healthcare — Health Information Services

Teladoc Health, Inc. provides virtual healthcare services worldwide. It operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical services, specialty medical, chronic condition management, and mental health services, as well as technologies and enterprise telehealth solutions for hospitals and health systems. Its BetterHelp segment operates a mental health platform that provides online counselling and therapy services through websites, mobile applications, phones, and text-based interactions by its licensed clinicians. The company offers its products and services under the Teladoc and BetterHelp brands. It serves employers, health plans, hospitals and health systems, insurance companies, and financial services companies, as well as individual members. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was incorporated in 2002 and is headquartered in New York, New York.

Buy 2.5 / 5 20 analysts
$8.92
$-0.79 (-8.14%)
Target: $7.40 (-17.0%)
Sign in to add TDOC to a watchlist or set price alerts.

Price History

52-Week Range

Fundamentals

Market Cap$1.65B
P/E Ratio (TTM)-
Forward P/E-14.09
EPS (TTM)$-0.97
Dividend Yield-
Profit Margin-6.81%
Revenue Growth-2.50%
ROE-12.39%
Debt/Equity77.68
Recommendation Buy 2.5
Analyst Target$7.40
Analysts20
Indexes NYSE

Technical Indicators

RSI (14)78.2
Beta2.14
SMA 20-
SMA 40-
52-Week High$9.77
52-Week Low$4.40
50-Day Avg$7.03
200-Day Avg$6.81
Avg Volume$4.65M
Volume$4.74M

Performance Analysis

NEUTRAL

TDOC presents a mixed picture with both positive and negative indicators.

+ Showing strength at 84% of its 52-week range.
- RSI at 78.2 indicates overbought conditions — a pullback may be due.
+ Price is above both the 50-day and 200-day moving averages — strong uptrend.
- Revenue declined 2.5% year-over-year.
- Operating at a loss with -6.8% margin.
+ Wall Street consensus is "Buy" from 20 analysts.
- Average analyst target of $7.40 implies 17.0% downside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 02, 2026 13:33 UTC

Back to Screener Export Report